Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Small Molecule Inhibitors of HER2 Inhibit Proliferative Signaling and Promote Apoptosis in Ph+ ALL

Mary E Irwin, PhD, Laura Nelson, PhD, Janice M Santiago-O'Farrill, Claudia P Miller, PhD, Doris R. Siwak, PhD, Gordon B. Mills, MD, PhD, Shulin Li, PhD, Dennis P Hughes, MD, PhD, Joya Chandra, PhD

Blood (2011) 118 (21): 1397.

https://doi.org/10.1182/blood.V118.21.1397.1397

Published: 2011

Journal Articles

Protein Expression Signatures Determined by Reverse Phase Proteins Arrays (RPPA) Accurately Predict FLT3-ITD Mutation Status in AML.

Steven M. Kornblau, MD, YiHua Qiu, MD, Wenjing Chen, MD, Srdan Verstovsek, MD, Kevin R. Coombes, PhD, Gordon B. Mills, MD, PhD

Blood (2007) 110 (11): 2398.

https://doi.org/10.1182/blood.V110.11.2398.2398

Published: 2007

Journal Articles

High Throughput Proteomic Analysis of 559 Acute Myelogenous Leukemia (AML) Patient Samples on a Single Slide Using Reverse Phase Proteins Arrays (RPPA): Analysis of Signal Transduction Pathway (STP) and Apoptosis Regulating Proteins.

Steven M. Kornblau, MD, YiHua Qiu, MD, MS, Raoul Tibes, MD, Wenjing Chen, MD, MS, Elizabeth Lemker, Michael Andreeff, MD, PhD, Kevin R. Coombes, PhD, Gordon B. Mills, MD, PhD

Blood (2006) 108 (11): 107.

https://doi.org/10.1182/blood.V108.11.107.107

Published: 2006

Journal Articles

Classification of Acute Myelogenous Leukemia (AML) Based on Patterns of Signal Transduction Pathway (STP) and Apoptosis Regulating Protein Activation Determined by Reverse Phase Proteins Arrays (RPPA).

Raoul Tibes, MD, YiHua Qiu, MD, Kevin R. Coombes, Ph.D, David Gold, PhD, Gordon B. Mills, MD., PhD, Steven M. Kornblau, MD

Blood (2005) 106 (11): 484.

https://doi.org/10.1182/blood.V106.11.484.484

Published: 2005

Journal Articles

Time Course Proteomic Profiling of Signal Transduction and Apoptosis Pathways in AML Survivor Cells Using Reverse Phase Protein Lysate Microarray (RPPA) Reveals Differential Effect of Time, Dose and Agent(s).

Steven M. Kornblau, MD, YiHua Qiu, MD, Raoul Tibes, MD, Yiling Lu, MD, Gordon B. Mills, MD. PhD

Blood (2005) 106 (11): 1219.

https://doi.org/10.1182/blood.V106.11.1219.1219

Published: 2005

Journal Articles

Differential Effects of Three Small Molecules Blocking Phosphatidylinositol-3 Kinase or AKT in Hodgkin Disease Cell Lines: Induction of Apoptosis and Cell Cycle Arrest.

Georgios V. Georgakis, MD, Yang Li, MSc, Georgios Z. Rassidakis, MD, Jeffrey L. Medeiros, MD, Gordon B. Mills, MD, PhD, Anas Younes, MD

Blood (2004) 104 (11): 428.

https://doi.org/10.1182/blood.V104.11.428.428

Published: 2004

NARROW

Small Molecule Inhibitors of HER2 Inhibit Proliferative Signaling and Promote Apoptosis in Ph+ ALL

Protein Expression Signatures Determined by Reverse Phase Proteins Arrays (RPPA) Accurately Predict FLT3-ITD Mutation Status in AML.

High Throughput Proteomic Analysis of 559 Acute Myelogenous Leukemia (AML) Patient Samples on a Single Slide Using Reverse Phase Proteins Arrays (RPPA): Analysis of Signal Transduction Pathway (STP) and Apoptosis Regulating Proteins.

Classification of Acute Myelogenous Leukemia (AML) Based on Patterns of Signal Transduction Pathway (STP) and Apoptosis Regulating Protein Activation Determined by Reverse Phase Proteins Arrays (RPPA).

Time Course Proteomic Profiling of Signal Transduction and Apoptosis Pathways in AML Survivor Cells Using Reverse Phase Protein Lysate Microarray (RPPA) Reveals Differential Effect of Time, Dose and Agent(s).

Differential Effects of Three Small Molecules Blocking Phosphatidylinositol-3 Kinase or AKT in Hodgkin Disease Cell Lines: Induction of Apoptosis and Cell Cycle Arrest.

Email alerts

ASH Publications

American Society of Hematology

Small Molecule Inhibitors of HER2 Inhibit Proliferative Signaling and Promote Apoptosis in Ph+ ALL

Protein Expression Signatures Determined by Reverse Phase Proteins Arrays (RPPA) Accurately Predict FLT3-ITD Mutation Status in AML.

High Throughput Proteomic Analysis of 559 Acute Myelogenous Leukemia (AML) Patient Samples on a Single Slide Using Reverse Phase Proteins Arrays (RPPA): Analysis of Signal Transduction Pathway (STP) and Apoptosis Regulating Proteins.

Classification of Acute Myelogenous Leukemia (AML) Based on Patterns of Signal Transduction Pathway (STP) and Apoptosis Regulating Protein Activation Determined by Reverse Phase Proteins Arrays (RPPA).

Time Course Proteomic Profiling of Signal Transduction and Apoptosis Pathways in AML Survivor Cells Using Reverse Phase Protein Lysate Microarray (RPPA) Reveals Differential Effect of Time, Dose and Agent(s).

Differential Effects of Three Small Molecules Blocking Phosphatidylinositol-3 Kinase or AKT in Hodgkin Disease Cell Lines: Induction of Apoptosis and Cell Cycle Arrest.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only